These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8583877)

  • 61. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
    Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
    Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Targeted tumor MRI with gadobutrol-loaded anti-HER2 immunoliposomes.
    Chen W; Liu B; Chen J; Liu G; Liu X
    Acta Radiol; 2017 May; 58(5):573-580. PubMed ID: 27565629
    [TBL] [Abstract][Full Text] [Related]  

  • 63. In vivo MR/optical imaging for gastrin releasing peptide receptor of prostate cancer tumor using Gd-TTDA-NP-BN-Cy5.5.
    Lin YH; Dayananda K; Chen CY; Liu GC; Luo TY; Hsu HS; Wang YM
    Bioorg Med Chem; 2011 Feb; 19(3):1085-96. PubMed ID: 20493715
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biocompatible KMnF3 nanoparticular contrast agent with proper plasma retention time for in vivo magnetic resonance imaging.
    Liu ZJ; Song XX; Xu XZ; Tang Q
    Nanotechnology; 2014 Apr; 25(15):155101. PubMed ID: 24642699
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Segmentation of dynamic contrast enhanced magnetic resonance imaging data.
    Nielsen T; Mouridsen K; Maxwell RJ; Stødkilde-Jørgensen H; Østergaard L; Horsman MR
    Acta Oncol; 2008; 47(7):1265-70. PubMed ID: 18661437
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Gadolinium-ethoxybenzyl-DTPA, a new liver-specific magnetic resonance contrast agent. Kinetic and enhancement patterns in normal and cholestatic rats.
    Clément O; Mühler A; Vexler V; Berthezène Y; Brasch RC
    Invest Radiol; 1992 Aug; 27(8):612-9. PubMed ID: 1428739
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Contrast-enhanced magnetic resonance imaging estimation of altered capillary permeability in experimental mammary carcinomas after X-irradiation.
    Cohen FM; Kuwatsuru R; Shames DM; Neuder M; Mann JS; Vexler V; Rosenau W; Brasch RC
    Invest Radiol; 1994 Nov; 29(11):970-7. PubMed ID: 7890512
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
    Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
    Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Gadolinium chelate with DO3A conjugated 2-(diphenylphosphoryl)-ethyldiphenylphosphonium cation as potential tumor-selective MRI contrast agent.
    Chandrasekharan P; Yong CX; Poh Z; He T; He Z; Liu S; Robins EG; Chuang KH; Yang CT
    Biomaterials; 2012 Dec; 33(36):9225-31. PubMed ID: 23026708
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Preclinical evaluation of manganese carbonate particles for magnetic resonance imaging of the liver.
    Wisner ER; Merisko-Liversidge E; Kellar K; Katzberg RW; Karpinski PH; Amparo EG; Drake C; Griffey SM; Brock JM
    Acad Radiol; 1995 Feb; 2(2):140-7. PubMed ID: 9419538
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Manganese-based oral contrast agent for liver magnetic resonance imaging: evaluation of the time course and dose response of liver signal intensity enhancement.
    Rief M; Huppertz A; Asbach P; Franiel T; Schwenke C; Hamm B; Taupitz M; Wagner M
    Invest Radiol; 2010 Sep; 45(9):565-71. PubMed ID: 20644484
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Characterization of viable and nonviable myocardium at MR imaging: comparison of gadolinium-based extracellular and blood pool contrast materials versus manganese-based contrast materials in a rat myocardial infarction model.
    Flacke S; Allen JS; Chia JM; Wible JH; Periasamy MP; Adams MD; Adzamli IK; Lorenz CH
    Radiology; 2003 Mar; 226(3):731-8. PubMed ID: 12601183
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Comparison of gadolinium-DTPA and polylysine-gadolinium-DTPA--enhanced magnetic resonance imaging of hepatocarcinoma in the rat.
    Grandin C; Van Beers BE; Demeure R; Goudemant JF; Mottet I; Pringot J
    Invest Radiol; 1995 Oct; 30(10):572-81. PubMed ID: 8557496
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Distribution of gadomelitol in a human breast tumor model in mice.
    Corot C; Robert P; Lancelot E; Martinell A; Santus R
    MAGMA; 2005 Jul; 18(3):138-43. PubMed ID: 16047191
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Magnetic resonance imaging-histomorphologic correlation studies on paramagnetic metalloporphyrins in rat models of necrosis.
    Ni Y; Petré C; Miao Y; Yu J; Cresens E; Adriaens P; Bosmans H; Semmler W; Baert AL; Marchal G
    Invest Radiol; 1997 Dec; 32(12):770-9. PubMed ID: 9406018
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Polylysine-Gd-DTPAn and polylysine-Gd-DOTAn coupled to anti-CEA F(ab')2 fragments as potential immunocontrast agents. Relaxometry, biodistribution, and magnetic resonance imaging in nude mice grafted with human colorectal carcinoma.
    Curtet C; Maton F; Havet T; Slinkin M; Mishra A; Chatal JF; Muller RN
    Invest Radiol; 1998 Oct; 33(10):752-61. PubMed ID: 9788138
    [TBL] [Abstract][Full Text] [Related]  

  • 77. MRI Monitoring of Tumor-Selective Anticancer Drug Delivery with Stable Thermosensitive Liposomes Triggered by High-Intensity Focused Ultrasound.
    Kim HR; You DG; Park SJ; Choi KS; Um W; Kim JH; Park JH; Kim YS
    Mol Pharm; 2016 May; 13(5):1528-39. PubMed ID: 26998616
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Visual targeted therapy of hepatic cancer using homing peptide modified calcium phosphate nanoparticles loading doxorubicin guided by T1 weighted MRI.
    Zhang NN; Yu RS; Xu M; Cheng XY; Chen CM; Xu XL; Lu CY; Lu KJ; Chen MJ; Zhu ML; Weng QY; Hui JG; Zhang Q; Du YZ; Ji JS
    Nanomedicine; 2018 Oct; 14(7):2167-2178. PubMed ID: 30017962
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tumor uptake of [48V]vanadyl-chlorine e6Na as a tumor-imaging agent in tumor-bearing mice.
    Iwai K; Kimura S; Ido T; Iwata R
    Int J Rad Appl Instrum B; 1990; 17(8):775-80. PubMed ID: 2079424
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Localizing efficiency of [48V]vanadyl-pheophorbide in tumor as a new tumor imaging agent.
    Iwai K; Ido T; Iwata R; Kawamura M; Kimura S
    Int J Rad Appl Instrum B; 1989; 16(8):783-9. PubMed ID: 2621113
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.